Active substance
Results for the substance pegvisomant
4 results
About this active substance
Pegvisomant is a growth hormone receptor antagonist used in the treatment of acromegaly, a condition caused by excessive growth hormone production. It works by blocking the effects of growth hormone on tissues.
The medication is administered subcutaneously, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and undergo regular tests to monitor growth hormone and IGF-1 levels.
Patients should be aware of potential side effects, such as injection site reactions, fatigue, or elevated liver enzymes. It is important to inform the doctor of any unusual symptoms.
Common side effects include injection site reactions, fatigue, and elevated liver enzymes. In rare cases, severe reactions such as hepatotoxicity or allergic reactions may occur. Patients should be informed of these risks before use.
The medication is administered subcutaneously, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and undergo regular tests to monitor growth hormone and IGF-1 levels.
Patients should be aware of potential side effects, such as injection site reactions, fatigue, or elevated liver enzymes. It is important to inform the doctor of any unusual symptoms.
Common side effects include injection site reactions, fatigue, and elevated liver enzymes. In rare cases, severe reactions such as hepatotoxicity or allergic reactions may occur. Patients should be informed of these risks before use.
-
-
SOMAVERT 10mg powder and solvent for solution for injection PFIZER ORIGINAL MEDICINE
-
SOMAVERT 15mg powder and solvent for solution for injection PFIZER ORIGINAL MEDICINE
-
SOMAVERT 20mg lyophilisate and solvent for solution for injection PFIZER ORIGINAL MEDICINE